Anderson DJ - Search Results

1

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.

Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP. Donnelly-Roberts DL, et al. Among authors: anderson dj. J Pharmacol Exp Ther. 1998 May;285(2):777-86. J Pharmacol Exp Ther. 1998. PMID: 9580626

2

A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor.

Rueter LE, Donnelly-Roberts DL, Curzon P, Briggs CA, Anderson DJ, Bitner RS. Rueter LE, et al. Among authors: anderson dj. CNS Drug Rev. 2006 Summer;12(2):100-12. doi: 10.1111/j.1527-3458.2006.00100.x. CNS Drug Rev. 2006. PMID: 16958984 Free PMC article. Review.

3

In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.

Malysz J, Grønlien JH, Anderson DJ, Håkerud M, Thorin-Hagene K, Ween H, Wetterstrand C, Briggs CA, Faghih R, Bunnelle WH, Gopalakrishnan M. Malysz J, et al. Among authors: anderson dj. J Pharmacol Exp Ther. 2009 Jul;330(1):257-67. doi: 10.1124/jpet.109.151886. Epub 2009 Apr 23. J Pharmacol Exp Ther. 2009. PMID: 19389923

4

In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.

Malysz J, Anderson DJ, Grønlien JH, Ji J, Bunnelle WH, Håkerud M, Thorin-Hagene K, Ween H, Helfrich R, Hu M, Gubbins E, Gopalakrishnan S, Puttfarcken PS, Briggs CA, Li J, Meyer MD, Dyhring T, Ahring PK, Nielsen EØ, Peters D, Timmermann DB, Gopalakrishnan M. Malysz J, et al. Among authors: anderson dj. J Pharmacol Exp Ther. 2010 Sep 1;334(3):863-74. doi: 10.1124/jpet.110.167072. Epub 2010 May 26. J Pharmacol Exp Ther. 2010. PMID: 20504915

5

Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.

Sullivan JP, Decker MW, Donnelly-Roberts D, Brioni JD, Bannon AW, Holladay MW, Anderson DJ, Briggs CA, Williams M, Arneric SP. Sullivan JP, et al. Among authors: anderson dj. Proc West Pharmacol Soc. 1995;38:127-30. Proc West Pharmacol Soc. 1995. PMID: 7480004 Review.

6

Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.

Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP. Decker MW, et al. Among authors: anderson dj. Eur J Pharmacol. 1995 Jun 23;280(1):79-89. doi: 10.1016/0014-2999(95)00191-m. Eur J Pharmacol. 1995. PMID: 7498257

7

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.

Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, et al. Arneric SP, et al. Among authors: anderson dj. J Pharmacol Exp Ther. 1994 Jul;270(1):310-8. J Pharmacol Exp Ther. 1994. PMID: 7518514

8

Characterization of [3H]ABT-418: a novel cholinergic channel ligand.

Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP, et al. Anderson DJ, et al. J Pharmacol Exp Ther. 1995 Jun;273(3):1434-41. J Pharmacol Exp Ther. 1995. PMID: 7791118

9

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ, et al. Sullivan JP, et al. Among authors: anderson dj. J Pharmacol Exp Ther. 1994 Nov;271(2):624-31. J Pharmacol Exp Ther. 1994. PMID: 7965777

10

Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

Anderson DJ, Arneric SP. Anderson DJ, et al. Eur J Pharmacol. 1994 Mar 3;253(3):261-7. doi: 10.1016/0014-2999(94)90200-3. Eur J Pharmacol. 1994. PMID: 8200419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,295 results

Search Page